Your browser doesn't support javascript.
loading
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.
Palmier, E; De Miguel, R; Montejano, R; Busca, C; Micán, R; Ramos, L; Cadiñanos, J; Serrano, L; Bernardino, J I; Pérez-Valero, I; Valencia, E; Arribas, J R; Montes, M L; González-García, J; Martín-Carbonero, L.
Affiliation
  • Palmier E; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • De Miguel R; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Montejano R; CIBER Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Busca C; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Micán R; CIBER Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Ramos L; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Cadiñanos J; CIBER Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Serrano L; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Bernardino JI; CIBER Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Pérez-Valero I; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Valencia E; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Arribas JR; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • Montes ML; Hospital Universitario La Paz, IdiPaz, Madrid, Spain.
  • González-García J; CIBER Infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Martín-Carbonero L; Hospital Universitario Reina Sofía, Córdoba, Spain.
HIV Med ; 24(9): 1013-1019, 2023 09.
Article in En | MEDLINE | ID: mdl-37194419
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Guideline Limits: Female / Humans / Male Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2023 Type: Article Affiliation country: Spain